Email UpdatesLiterature Collection
Collection Insights
10K+
References
9K+
Articles
1400+
Grey Literature
4500+
Opioids & SU
The Literature Collection contains over 10,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More
Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).
10858 Results
3943
Federal plan for prescriber education on opioids misses opportunities
Type: Journal Article
Year: 2012
Publication Place: United States
Topic(s):
Opioids & Substance Use
See topic collection
, Education & Workforce
See topic collection
Reference Links: View the PubMed citation for Federal plan for prescriber education on opioids misses opportunities
3947
Federally Qualified Health Centers as Partners in Rural Health Care Delivery Reimagined
Type: Journal Article
Year: 2019
Publication Place: United States
Topic(s):
Education & Workforce
See topic collection
, Financing & Sustainability
See topic collection
, Healthcare Disparities
See topic collection
Reference Links:
View the DOI record for Federally Qualified Health Centers as Partners in Rural Health Care Delivery Reimagined
View DOI Record
View the PubMed citation for Federally Qualified Health Centers as Partners in Rural Health Care Delivery Reimagined3948
Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona
Type: Journal Article
Year: 2021
Topic(s):
Education & Workforce
See topic collection
, Healthcare Disparities
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona
View DOI Record
View the PubMed citation for Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona3950
Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?
Type: Journal Article
Year: 2018
Abstract: Major policy efforts are being aimed at combating the epidemic of opioid addiction and overdose deaths. In response to the epidemic, the medical community and policy makers have attempted to intervene; to date, these varied approaches have done little to reverse the increase in mortality related to opioid overdose. One factor that has complicated efforts to control overdose deaths has been the emergence of a public health crisis related to illicit fentanyl. The rise in fentanyl-related overdose deaths means that new approaches are needed to combat the opioid epidemic, including adoption of harm reduction strategies. Specific strategies that should be considered as part of efforts to combat the opioid crisis include safe drug consumption sites, anonymous drug-checking services, updated naloxone distribution policies, harm reduction-oriented policing, expansion of evidence-based pharmacological treatments in criminal justice and emergency department settings, and stigma-reduction messaging emphasizing the risks of fentanyl.
Topic(s):
Healthcare Policy
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?
View DOI Record
View the PubMed citation for Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?3953
Fentanyl laced heroin and its contribution to a spike in heroin overdose in Miami-Dade County
Type: Journal Article
Year: 2017
Publication Place: United States
Topic(s):
Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Fentanyl laced heroin and its contribution to a spike in heroin overdose in Miami-Dade County
View DOI Record
View the PubMed citation for Fentanyl laced heroin and its contribution to a spike in heroin overdose in Miami-Dade County3956
Field Detection of Drugs of Abuse in Oral Fluid Using the Alere DDS(R)2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Type: Journal Article
Year: 2018
Publication Place: England
Abstract: The collection and analysis of drugs in oral fluid (OF) at the roadside has become more feasible with the introduction of portable testing devices such as the Alere DDS(R)2 Mobile Test System (DDS(R)2). The objective of this study was to compare the on-site results for the DDS(R)2 to laboratory-based confirmatory assays with respect to detection of drugs of abuse in human subjects. As part of a larger Institutional Review Board approved study, two OF samples were collected from each participant at a music festival in Miami, FL, USA. One OF sample was field screened using the DDS(R)2, and a confirmatory OF sample was collected using the Quantisal OF collection device and submitted to the laboratory for testing. In total, 124 subjects participated in this study providing two contemporaneous OF samples. DDS(R)2 field screening yielded positive results for delta-9-tetrahydrocannabinol (THC) (n = 27), cocaine (n = 12), amphetamine (n = 3), methamphetamine (n = 3) and benzodiazepine (n = 1). No opiate-positive OF samples were detected. For cocaine, amphetamine, methamphetamine and benzodiazepines, the DDS(R)2 displayed sensitivity, specificity and accuracy of 100%. For THC, the DDS(R)2 displayed sensitivity of 90%, specificity of 100% and accuracy of 97.5%, when the threshold for confirmation matched that of the manufacturers advertised cut-off. When this confirmatory threshold was lowered to the analytical limit of detection (i.e., 1 ng/mL), apparent device performance for THC was poorer due to additional samples testing positive by confirmatory assay that had tested negative on the DDS(R)2, demonstrating a need for correlation between manufacturer cut-off and analytical reporting limit. These results from drug-using subjects demonstrate the value of field-based OF testing, and illustrate the significance of selecting an appropriate confirmation cut-off concentration with respect to performance evaluation and detection of drug use.
Topic(s):
Opioids & Substance Use
See topic collection